Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating atezolizumab in combination with SBRT and surgery for relapsed osteosarcoma (including pulmonary recurrence), currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)

Snippet

Sponsor: Emory University | Conditions: Osteosarcoma, Pulmonary Recurrence of Osteosarcoma | Phase 1 | Status: RECRUITING